Cargando…

Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability

Latrepirdine/Dimebon is a small-molecule compound with attributed neurocognitive-enhancing activities, which has recently been tested in clinical trials for the treatment of Alzheimer's and Huntington's disease. Latrepirdine has been suggested to be a neuroprotective agent that increases m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weisová, P, Alvarez, S P, Kilbride, S M, Anilkumar, U, Baumann, B, Jordán, J, Bernas, T, Huber, H J, Düssmann, H, Prehn, J H M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818013/ https://www.ncbi.nlm.nih.gov/pubmed/24150226 http://dx.doi.org/10.1038/tp.2013.92

Ejemplares similares

Defining external factors that determine neuronal survival, apoptosis and necrosis during excitotoxic injury using a high content screening imaging platform
por: Anilkumar, Ujval, et al.
Publicado: (2017)

AMP kinase–mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis
por: Concannon, Caoimhín G., et al.
Publicado: (2010)

Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome-c release
por: Huber, Heinrich J, et al.
Publicado: (2011)

The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity
por: Porter, Tenielle, et al.
Publicado: (2016)

Differences in bioavailability and cognitive-enhancing activity exerted by different crystal polymorphs of latrepirdine (Dimebon(®))
por: Gorin, Boris I., et al.
Publicado: (2023)

Design, Synthesis, Molecular Docking Study and Biological Evaluation of Novel γ-Carboline Derivatives of Latrepirdine (Dimebon) as Potent Anticancer Agents
por: Voggu, Ramakrishna, et al.
Publicado: (2023)

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases
por: Bharadwaj, P R, et al.
Publicado: (2013)

Mitochondrial Pharmacology of Dimebon (Latrepirdine) Calls for a New Look at its Possible Therapeutic Potential in Alzheimer’s Disease
por: Eckert, Schamim H, et al.
Publicado: (2018)

Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain
por: Steele, John W., et al.
Publicado: (2012)

Single-cell time-lapse imaging of intracellular O(2) in response to metabolic inhibition and mitochondrial cytochrome-c release
por: Düssmann, Heiko, et al.
Publicado: (2017)

Atrial AMP-activated protein kinase is critical for prevention of dysregulation of electrical excitability and atrial fibrillation
por: Su, Kevin N., et al.
Publicado: (2022)

A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice
por: Chaprov, Kirill, et al.
Publicado: (2021)

Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo
por: Steele, John W, et al.
Publicado: (2009)

AMP-activated protein kinase-α1 as an activating kinase of TGF-β-activated kinase 1 has a key role in inflammatory signals
por: Kim, S Y, et al.
Publicado: (2012)

Opposing Activity Changes in AMP Deaminase and AMP-Activated Protein Kinase in the Hibernating Ground Squirrel
por: Lanaspa, Miguel A., et al.
Publicado: (2015)

AMP-Activated Protein Kinase Signalling
por: Neumann, Dietbert, et al.
Publicado: (2019)

Real-time single cell analysis of Smac/DIABLO release during apoptosis
por: Rehm, Markus, et al.
Publicado: (2003)

Metabolic Targeting of Breast Cancer Cells With the 2-Deoxy-D-Glucose and the Mitochondrial Bioenergetics Inhibitor MDIVI-1
por: Lucantoni, Federico, et al.
Publicado: (2018)

Bmf upregulation through the AMP-activated protein kinase pathway may protect the brain from seizure-induced cell death
por: Moran, C, et al.
Publicado: (2013)

Aging-Associated Reductions in AMP-Activated Protein Kinase Activity and Mitochondrial Biogenesis
por: Reznick, Richard M., et al.
Publicado: (2007)

BH3-Only protein bmf is required for the maintenance of glucose homeostasis in an in vivo model of HNF1α-MODY diabetes
por: Pfeiffer, S, et al.
Publicado: (2015)

The potent, indirect adenosine monophosphate-activated protein kinase activator R419 attenuates mitogen-activated protein kinase signaling, inhibits nociceptor excitability, and reduces pain hypersensitivity in mice
por: Mejia, Galo L., et al.
Publicado: (2016)

AMP-Activated Protein Kinase Signalling in Cancer and Cardiac Hypertrophy
por: Lipovka, Yulia, et al.
Publicado: (2015)

Redox Regulation of the AMP-Activated Protein Kinase
por: Han, Yingying, et al.
Publicado: (2010)

AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net Phosphorylation
por: Gowans, Graeme J., et al.
Publicado: (2013)

Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly
por: Hinchy, Elizabeth C., et al.
Publicado: (2018)

Deconvoluting AMP-activated protein kinase (AMPK) adenine nucleotide binding and sensing
por: Gu, Xin, et al.
Publicado: (2017)

Regulation of AMP-activated protein kinase by natural and synthetic activators
por: Grahame Hardie, David
Publicado: (2016)

Counterregulation of cAMP-directed kinase activities controls ciliogenesis
por: Porpora, Monia, et al.
Publicado: (2018)

Protein kinase C phosphorylates AMP-activated protein kinase α1 Ser487
por: Heathcote, Helen R., et al.
Publicado: (2016)

A Highly Sensitive Non-Radioactive Activity Assay for AMP-Activated Protein Kinase (AMPK)
por: Yan, Yan, et al.
Publicado: (2017)

Oestrogen receptors interact with the α-catalytic subunit of AMP-activated protein kinase
por: Lipovka, Yulia, et al.
Publicado: (2015)

AMP-activated protein kinase controls liposaccharide-induced hyperpermeability
por: Castanares-Zapatero, D, et al.
Publicado: (2012)

AMP-Activated Kinase AMPK Is Expressed in Boar Spermatozoa and Regulates Motility
por: Hurtado de Llera, Ana, et al.
Publicado: (2012)

Post-Translational Modifications of the Energy Guardian AMP-Activated Protein Kinase
por: Ovens, Ashley J., et al.
Publicado: (2021)

BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose
por: Lucantoni, Federico, et al.
Publicado: (2018)

Mitochondrial Carrier Homolog 2 Functionally Co-operates With BH3 Interacting-Domain Death Agonist in Promoting Ca(2+)-Induced Neuronal Injury
por: D’Orsi, Beatrice, et al.
Publicado: (2021)

Role of AMP-Activated Protein Kinase in the Control of Appetite
por: Kola, B
Publicado: (2008)

AMP-activated protein kinase: An emerging target for ginseng
por: Jeong, Kyong Ju, et al.
Publicado: (2013)

AMP-activated protein kinase – not just an energy sensor
por: Hardie, David Grahame, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_do9jo7764e9g307tidqgol69mo